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Edited by Henrik DohlmancAMP is the indispensable second messenger regulating cell
metabolism and function in response to extracellular hormones
and neurotransmitters. cAMP is produced via the activation of
G protein–coupled receptors located at both the cell surface
and inside the cell. Recently, Tsvetanova et al. explored cAMP
generation in distinct locations and the impact on respective
cell functions. Using a phospho-proteomic analysis, they pro-
vide insight into the unique role of localized cAMP production
in cellular phospho-responses.
Similar to other extracellular stimuli, hormones and neu-
rotransmitters transmit signals into cells by binding to
different G protein–coupled receptors (GPCRs), which
constitute the largest receptor family in the body. Peptidic and
nonpeptidic hormones such as vasopressin and epinephrine,
respectively, activate distinct GPCRs to induce the synthesis of
cAMP, the second messenger molecule that activates PKA,
which in turn regulates numerous metabolic functions (e.g.,
glycogen metabolism, water homeostasis). The established
paradigm of GPCR signaling via cAMP postulates that ligand
binding to its cognate receptor induces conformational
changes to the latter, enabling coupling and activation of the
heterotrimeric Gs protein, the guanine nucleotide-binding
protein that stimulates activity of transmembrane adenylate
cyclase (AC) localized at the plasma membrane. Activated AC
converts ATP into cAMP, a reaction that is rapidly terminated
by the GTPase activity of Gs and by a cascade of reactions and
interactions that desensitize the ligand-activated receptor,
including (1) receptor phosphorylation, (2) interaction of the
phosphorylated receptor with β-arrestins, and (3) internaliza-
tion of the receptor–arrestin complex into early endosomes.
Once in endosomes, the agonist dissociates from the receptor
and the receptor is either degraded in lysosomes (down-
regulation) or dephosphorylated and recycled back to the
plasma membrane for a new cycle of activation and signaling
(resensitization) (reviewed in (1)).
Following initial studies on the parathyroid hormone and
thyroid-stimulating hormone receptors back in 2009, another
mode of cAMP signaling has been identified for several other
GPCRs (reviewed in (1)). In this recently recognized model,
receptors continue to signal throughGs after internalization into
early endosomes to induce a second wave of cAMP production* For correspondence: Jean-Pierre Vilardaga, jpv@pitt.edu.
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also likely has physiological relevance for human health and
disease (4, 5) (Fig. 1). Understanding molecular and cellular
mechanisms of endosomal cAMP signaling thus has potential
medical significance for the development of new therapies to
treat bone and mineral diseases caused by hypocalcemia, a
condition of low Ca2+ level in the blood (reviewed in (1, 3)).
While essential mechanisms governing endosomal GPCR
signaling via cAMP are emerging (6, 7), many key questions
remain to be solved. One of these—how location bias in cAMP
signaling can trigger unique cellular functions—has been
recently addressed by Tsvetanova et al. (8).
One technical challenge when studying GPCR signaling is
the difficulty in detecting compartmentalized cAMP produc-
tion because of the dynamic membrane trafficking in live cells.
To circumvent this issue, Tsvetanova et al. (8) used a previ-
ously described optogenetic approach in which bacteria-
derived photoactivable adenylyl cyclase (bPAC) is targeted to
distinct subcellular compartments, such as early endosomes,
the cytosol, and the plasma membrane, to induce location-
selective cAMP production after photo-stimulation by blue
light. Because PKA is directly activated by cAMP, resulting in
changes in the phosphorylation status of many downstream
targets, the authors asked whether location bias of cAMP
generation results in distinct or similar cellular phospho-
proteomes. To this end, the authors applied a SILAC (Stable
Isotope Labeling by Amino acids in Cell culture)-based pro-
teomics approach to study the cellular phospho-proteome in
human embryonic kidney 293 cells. The experimental princi-
ple is based on two populations of cells that are cultured side
by side in media containing either “light” (12C,14N) or “heavy”
(13C,15N) isotopic forms of arginine and lysine. “Light” cells,
not photo-stimulated, serve as reference control. After photo-
stimulation of “heavy” cells, lysates of an equal number of
“light” and “heavy” cells are mixed, and phospho-peptides are
then enriched by immobilized metal affinity chromatography
and subjected to online LC/MS/MS analysis. Because 13C and
15N do not cause significant isotope effects, “light-” and
“heavy”-labeled peptides are chemically identical but different
in mass. This mass shift is detected by MS such that the ratio
of peak intensities in the mass spectrum reflects the relative
abundance of each phospho-peptide. This system proved to be
reliable, given that one-third of all known GPCR/cAMP
phosphorylation targets were found to be phosphorylated in
response to cytosolic cAMP generated by cytosol-targetedJ. Biol. Chem. (2021) 297(3) 101118 1
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Figure 1. Alternate modes of GPCR signaling via cAMP and the phosphoproteome. The first pool of cAMP production takes place at the cell membrane
after activation of Gs by the agonist-bound receptors (step 1). This cAMP response is usually short-lived because of the action of phosphodiesterases and
rapid receptor desensitization, followed by receptor endocytosis (step 2). Eventually, internalized receptors induce a second pool of cAMP generation that
originates from ligand–GPCR complexes in endosomes. Each location-derived cAMP pool triggers a unique phospho-proteomic response inside the cell. The
phosphoproteome heat map is from Tsvetanova et al. (8). AC, adenylate cyclase; GPCR, G protein–coupled receptor.
EDITORS’ PICK HIGHLIGHT: Decoding endosomal cAMP signalingbPAC. In addition, many of these targets contained the PKA
target motif R-R/K-X-p(S/T), suggesting that all novel sites
identified are likely to be linked to cAMP signaling.
The first insight of the study stems from the Gene Ontology
and network analyses, unveiling that upon cytosolic cAMP
production, a group of RNA-processing proteins become
phosphorylated, a Gene Ontology category that has not been
previously associated with cAMP signaling. This exciting
finding will likely prompt more research toward better un-
derstanding of post-transcriptional regulation of GPCR
signaling–mediated gene expression. The second insight is the
observation that changes in protein phosphorylation are
significantly higher when cAMP is generated from endosomes
rather than the plasma membrane, despite very similar total
amounts of cAMP generated at both locations (Fig. 1). How-
ever, the analysis of downregulated rather than upregulated
phosphopeptides revealed protein phosphatase 2A to be a
highly probable target of endosomal cAMP signaling, as its
phosphorylation (and activation) at PKA target residue S573
occurred only in response to endosomal cAMP production.
While mimicking the duration of cAMP generated by GPCRs
via photo-stimulation of cAMP with the bPAC tool is chal-
lenging, the authors verified that bPAC phospho-proteomic
data are consistent with those reporting the effect of recep-
tor internalization upon phosphorylation of PKA substrates for
two distinct GPCRs: the vasopressin type 2 receptor, known to
evoke long-lasting endosomal cAMP production in recombi-
nant and native cells (9), and the β2-adrenergic receptor, which
triggers short-lived endosomal cAMP (10). In both cases,
PKA-dependent phosphorylation is reduced when the receptor
is retained at the plasma membrane. This result supports a
previous study comparing the actions of location-biased
vasopressin type 2 receptor signaling on phosphorylation of
target proteins (9).
This study provides a valuable glimpse into possible
cellular processes specifically regulated by endosomal cAMP.
However, much remains to be learned. The next steps of this2 J. Biol. Chem. (2021) 297(3) 101118research will likely be (1) determining the mechanism by
which location bias generation of cAMP causes distinct
phospho-proteomic responses and (2) linking these responses
to the regulation of physiological processes. The first will
require studies involving, for example, the role of phosphodi-
esterases in the control of cAMP diffusion in cells. The second
might be addressed, at least in part, by cell proteomics
profiling of diverse tissues from small animals treated with
biased GPCR ligands stimulating cAMP from either the cell
surface or endosomes. From the work of Tsvetanova et al., one
overarching conclusion can be drawn. As location bias in
cAMP signaling contributes to a primary cell function by
regulating the phospho-proteomes, it shines the way to a
better understanding of endosomal GPCR function via G
proteins.
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